Finance

The new acquistiion is expected to help the company grow out its diagnostic capabilities.

The company's IPO included around 4.4 million shares. 

This new infusion of cash brings the company's total funding to $15M. 

Apostrophe is able to offer patients oral and topical acne medications. 

The opening day stock prices are listed at $8.90 and the deal is expected to give Talkspace $250 million in growth capital. 

The funds will be used to accelerate the expansion of its digital care platform for respiratory health. 

The company is planning to list the initial stock price somewhere between $20 and $23 per share. 

The acquired company, which focuses on the hair-loss space, caters to the U.K. market. 

This week's top stories include UnitedHealthcare re-examining a policy that allows it to deny ER claims, Apple unveiling walking stability assessments for the iPhone, and Mount Sinai catering to patients with limited English proficiency.

Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.